{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:05:07Z","timestamp":1768287907598,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.aprim.2022.102552","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:26:31Z","timestamp":1670379991000},"page":"102552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impacto del confinamiento por COVID-19 en la prescripci\u00f3n de benzodiacepinas"],"prefix":"10.1016","volume":"55","author":[{"given":"Sara","family":"Garc\u00eda Diez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edriam","family":"De Nicol\u00e1s Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Di\u00e9guez Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Fern\u00e1ndez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricio","family":"Su\u00e1rez Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Navarro Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102552_bib0125","first-page":"1","article-title":"Estrategias para la desprescripci\u00f3n de benzodiazepinas","volume":"22","author":"And\u00eda","year":"2014","journal-title":"BITN [Internet]."},{"key":"10.1016\/j.aprim.2022.102552_bib0130","series-title":"Gu\u00eda de consenso para el buen uso de las benzodiacepinas [Internet]","author":"Lligo\u00f1a Garreta","year":"2019"},{"key":"10.1016\/j.aprim.2022.102552_bib0135","unstructured":"Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a [Internet]. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. AEMPS; 2019. [Consultado 2 Sep 2022]. Disponible en: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/observatorio-de-uso-de-medicamentos\/informes-ansioliticos-hipnoticos\/"},{"key":"10.1016\/j.aprim.2022.102552_bib0140","unstructured":"Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el periodo 2000-2012 [Internet]. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. AEMPS; 2014. [Consultado 28 Nov 2020]: 1-4. Disponible en: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/ansioliticos_hipnoticos-2000-2012.pdf?x27361."},{"key":"10.1016\/j.aprim.2022.102552_bib0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.2020.9740","article-title":"Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020","volume":"324","author":"McGinty","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102552_bib0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamapsychiatry.2020.1057","volume":"77","author":"Xiang","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.aprim.2022.102552_bib0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamainternmed.2020.1562","article-title":"The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention","volume":"180","author":"Galea","year":"2020","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.aprim.2022.102552_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.aprim.2022.102552_bib0165","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/eurpub\/ckm020","article-title":"Prescription of benzodiazepines in general practice in the context of a man-made disaster: a longitudinal study","volume":"17","author":"Fassaert","year":"2007","journal-title":"Eur J Public Health."},{"key":"10.1016\/j.aprim.2022.102552_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1521\/psyc.65.3.207.20173","article-title":"60,000 Disaster Victims Speak: Part I. An Empirical Review of the Empirical Literature, 1981-2001","volume":"65","author":"Norris","year":"2002","journal-title":"Psychiatry."},{"key":"10.1016\/j.aprim.2022.102552_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jagp.2020.04.012","article-title":"Addressing Problems With Alcohol and Other Substances Among Older Adults During the COVID-19 Pandemic","volume":"28","author":"Satre","year":"2020","journal-title":"Am J Geriatr Psychiatry."},{"key":"10.1016\/j.aprim.2022.102552_bib0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12992-020-00589-w","article-title":"Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"16","author":"Salari","year":"2020","journal-title":"Global Health."},{"key":"10.1016\/j.aprim.2022.102552_bib0185","first-page":"e15816","article-title":"Benzodiazepine Misuse: An Epidemic Within a Pandemic","volume":"13","author":"Sarangi","year":"2021","journal-title":"Cureus [Internet]."},{"key":"10.1016\/j.aprim.2022.102552_bib0190","doi-asserted-by":"crossref","first-page":"e27664","DOI":"10.1097\/MD.0000000000027664","article-title":"Psychotropic medication prescribing during the COVID-19 pandemic","volume":"100","author":"Hirschtritt","year":"2021","journal-title":"Medicine."},{"key":"10.1016\/j.aprim.2022.102552_bib0195","doi-asserted-by":"crossref","first-page":"731297","DOI":"10.3389\/fpsyt.2021.731297","article-title":"Impact of the COVID-19 Pandemic on the General Mental Health in Sweden: No Observed Changes in the Dispensed Amount of Common Psychotropic Medications in the Region of Scania","volume":"12","author":"Wolfschlag","year":"2021","journal-title":"Front Psychiatry."},{"key":"10.1016\/j.aprim.2022.102552_bib0200","first-page":"335","article-title":"Evidencias y reflexiones sobre la COVID-19","volume":"16","author":"Minu\u00e9 Lorenzo","year":"2020","journal-title":"AMF [Internet]."},{"key":"10.1016\/j.aprim.2022.102552_bib0205","article-title":"Aspectos sociales de la pandemia y sus efectos sobre la Atenci\u00f3n Primaria en Espa\u00f1a","author":"Gavil\u00e1n","year":"2020","journal-title":"AMF [Internet]."},{"key":"10.1016\/j.aprim.2022.102552_bib0210","doi-asserted-by":"crossref","first-page":"102066","DOI":"10.1016\/j.ajp.2020.102066","article-title":"COVID-19 and mental health: A review of the existing literature","volume":"52","author":"Rajkumar","year":"2020","journal-title":"Asian J Psychiatr."},{"key":"10.1016\/j.aprim.2022.102552_bib0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbi.2020.05.048","article-title":"COVID-19 pandemic and mental health consequences: Systematic review of the current evidence","volume":"89","author":"Vindegaard","year":"2020","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.aprim.2022.102552_bib0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/da.23228","article-title":"The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada","volume":"39","author":"Uthayakumar","year":"2022","journal-title":"Depress Anxiety."},{"key":"10.1016\/j.aprim.2022.102552_bib0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.puhe.2021.10.005","article-title":"Psychotropic medications sales during COVID-19 outbreak in Italy changed according to the pandemic phases and related lockdowns","volume":"201","author":"Farina","year":"2021","journal-title":"Public Health."},{"key":"10.1016\/j.aprim.2022.102552_bib0230","doi-asserted-by":"crossref","first-page":"e2118441","DOI":"10.1001\/jamanetworkopen.2021.18441","article-title":"Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario Canada","volume":"4","author":"Campitelli","year":"2021","journal-title":"JAMA Network Open."},{"key":"10.1016\/j.aprim.2022.102552_bib0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1157\/13074791","article-title":"G\u00e9nero y psicof\u00e1rmacos: la opini\u00f3n de los prescriptores a trav\u00e9s de una investigaci\u00f3n cualitativa","volume":"35","author":"Gil","year":"2005","journal-title":"Atenci\u00f3n Primaria."},{"key":"10.1016\/j.aprim.2022.102552_bib0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5565\/rev\/periferia.699","article-title":"Feminizaci\u00f3n del consumo de benzodiacepinas","volume":"25","author":"L\u00f3pez","year":"2020","journal-title":"Perif\u00e8ria [Internet]."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722002724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722002724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:02:44Z","timestamp":1759323764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722002724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0212656722002724"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102552","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacto del confinamiento por COVID-19 en la prescripci\u00f3n de benzodiacepinas","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102552"}}